Hypertriglyceridemic Waist in Patients with Type 2 Diabetes: Its Relationship to Selected Markers of Vascular Damage.

Metabolic Syndrome and Related Disorders
D KarásekL Slavík

Abstract

Background: To evaluate the association between hypertriglyceridemic waist (HTGW), a promising marker of visceral adiposity and cardiovascular (CV) risk, and different indicators of vascular damage in type 2 diabetes (T2D) patients. Methods: This case-control study included 161 patients with T2D (91 males, 70 females) and 40 healthy controls (24 males, 16 females). HTWG was defined as waist circumference >90 cm in men or >85 cm in women and triglyceride concentrations >2 mmol/L. In addition to anthropometric and metabolic parameters, markers of endothelial dysfunction, namely von Willebrand factor (vWF) and plasminogen activator inhibitor-1 (PAI-1), were assessed. Arterial stiffness parameters were examined using the SphygmoCor system. Results: Individuals with T2D and HTGW showed the highest elevation of PAI-1 levels and significantly increased vWF levels compared with healthy controls. No significant differences in arterial stiffness markers were observed between T2D individuals. Age and, for several markers, systolic and/or diastolic blood pressure were identified as the main predictors for arterial stiffness, whereas PAI-1 and vWF levels were predicted by metabolic parameters. Conclusions: HTGW represents increased CV risk ...Continue Reading

References

May 1, 1997·Cardiovascular Research·G Y Lip, A Blann
May 13, 1998·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·B Janand-DelenneP Vague
Jul 16, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·K N FraynS W Coppack
Nov 1, 2005·Expert Opinion on Investigational Drugs·Dirk C Felmeden, Gregory Y H Lip
Nov 1, 2005·Journal of the American College of Cardiology·Carmel M McEnieryUNKNOWN ACCT Investigators
Apr 25, 2006·Metabolism: Clinical and Experimental·Ilse MertensLuc F Van Gaal
Sep 27, 2006·European Heart Journal·Stephane LaurentUNKNOWN European Network for Non-invasive Investigation of Large Arteries
May 15, 2007·Current Opinion in Lipidology·Marie-Christine AlessiIrène Juhan-Vague
Mar 19, 2008·Circulation·Alexander O SpielBernd Jilma
Jul 20, 2010·Journal of Thrombosis and Thrombolysis·David KarasekDalibor Novotny
May 11, 2012·Cardiology in Review·Tanja Dudenbostel, Stephen P Glasser
Jan 6, 2015·Atherosclerosis·Stuart B Prenner, Julio A Chirinos
Dec 5, 2015·The Journal of Clinical Endocrinology and Metabolism·You-Cheol HwangEdward J Boyko
Dec 9, 2016·International Journal of Molecular Sciences·Claudia R L Cardoso, Gil F Salles
Jun 20, 2017·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Jaromira GajdovaJosef Zadrazil
Aug 30, 2017·Frontiers in Cardiovascular Medicine·Manna LiJian Xu
May 3, 2018·Metabolic Syndrome and Related Disorders·Jaromíra SpurnáJosef Zadražil
Oct 20, 2018·Current Diabetes Reviews·Manuel Giraldo-Grueso, Darío Echeverri
Jan 22, 2019·Current Vascular Pharmacology·Andromachi ReklouVasilios Athyros

❮ Previous
Next ❯

Methods Mentioned

BETA
ion-exchange chromatography

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.